Concerto HealthAI
The Series C comes about two years after another $150 million raise.
ConcertAI is expanding its collaboration with Janssen to improve study design and increase diversity in clinical trials.
The collection of B2B AI companies already counts Concerto HealthAI among its numbers.
It's been a busy week for digital health funding, with more raises announced by Arcadia, Cardiologs, Covera and others.
The companies' partnership is yet another example of real-world data analysis coming to clinical trials.
The pharma company will gain access to Concerto Health's eurekaHealth, an AI and machine learning platform.